Hayase Hakariya

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Candida Albicans

Vascular Endothelial Growth Factor

Drug Administration

Top Venues

JMIR formative research

Journal of general and family medicine

BMJ sexual & reproductive health

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Hayase Hakariya, Akihhiko Ozaki, Shai Mulinari, Frank Moriarty, Tetsuya Tanimoto
Evaluating time to withdrawal of anti-Cancer drug indications that received FDA's accelerated approval. QJM : monthly journal of the Association of Physicians (2024)
Hayase Hakariya, Mutsuko Ohnishi, Tetsuya Tanimoto
Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions. Diabetes, obesity & metabolism (2024)
Fangjie Lyu, Hayase Hakariya, Haruka Hiraoka, Zhenmin Li, Noriaki Matsubara, Yonghao Soo, Fumitaka Hashiya, Kosuke Nakamoto, Zhaoma Shu, Kosuke Nakamoto, Yasuaki Kimura, Hiroshi Abe
Intracellular Delivery of Antisense Oligonucleotides by Tri-Branched Cyclic Disulfide Units. ChemMedChem (2024)
Hayase Hakariya, Tatsuki Ikejiri, Arisa Hakariya, Mayumi Hara
Gender disparities among prestigious biomedical award recipients in Japan: A cross sectional study. Health science reports 7 (9) (2024)
Hayase Hakariya, Takanao Hashimoto, Yosuke Suzuki, Tamae Hamaki, Tetsuya Tanimoto
Japan initiates a groundbreaking market test of over-the-counter emergency contraceptive pills with pharmacies as a first access point. BMJ sexual & reproductive health (2024)
Hayase Hakariya, Natsuki Yokoyama, Jeonse Lee, Arisa Hakariya, Tatsuki Ikejiri
Illicit Trade of Prescription Medications Through X (Formerly Twitter) in Japan: Cross-Sectional Study. JMIR formative research 8 (2024)
Hayase Hakariya, Natsuki Yokoyama, Jeonse Lee, Arisa Hakariya, Tatsuki Ikejiri
Illicit Trade of Prescription Medications Through X (Formerly Twitter) in Japan: Cross-Sectional Study. JMIR formative research 8 (2024)
Hayase Hakariya, Natsuki Yokoyama, Jeonse Lee, Arisa Hakariya, Tatsuki Ikejiri
Illicit Trade of Prescription Medications Through X (Formerly Twitter) in Japan: Cross-Sectional Study. JMIR formative research 8 (2024)
Hayase Hakariya, Frank Moriarty, Akihhiko Ozaki, Shai Mulinari, Hiroaki Saito, Tetsuya Tanimoto
Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals. Clinical and translational science 17 (7) (2024)
Hayase Hakariya, Frank Moriarty, Akihhiko Ozaki, Shai Mulinari, Hiroaki Saito, Tetsuya Tanimoto
Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals. Clinical and translational science 17 (7) (2024)
Hayase Hakariya, Mutsuko Ohnishi, Tetsuya Tanimoto
Japan initiates market authorization of weight-loss drug semaglutide under universal health coverage, but with stringent prescription restrictions. Diabetes, obesity & metabolism 26 (8) (2024)
Hayase Hakariya, Takanao Hashimoto, Yosuke Suzuki, Tamae Hamaki, Tetsuya Tanimoto
Japan initiates a groundbreaking market test of over-the-counter emergency contraceptive pills with pharmacies as a first access point. BMJ sexual & reproductive health 50 (3) (2024)
Hayase Hakariya, Natsuki Yokoyama, Jeonse Lee, Arisa Hakariya, Tatsuki Ikejiri
Illicit Trade of Prescription Medications Through X (Formerly Twitter) in Japan: Cross-Sectional Study. JMIR formative research 8 (2024)
Tatsuki Ikejiri, Hayase Hakariya, Haruna Kai, Natsuki Yokoyama, Arisa Hakariya
The "Okusuri Charm" movement in Japan: Prescription drug accessories emerging on X (Twitter). Journal of general and family medicine 25 (1) (2023)
Tatsuki Ikejiri, Hayase Hakariya, Haruna Kai, Natsuki Yokoyama, Arisa Hakariya
The "Okusuri Charm" movement in Japan: Prescription drug accessories emerging on X (Twitter). Journal of general and family medicine 25 (1) (2023)
Hayase Hakariya, Ippei Takashima, Misao Takemoto, Naotaka Noda, Shin-Ichi Sato, Motonari Uesugi
Non-genetic cell-surface modification with a self-assembling molecular glue. Chemical communications (Cambridge, England) 57 (12) (2021)